Rivian shares fell 8% amid the EV tax credit expiry and investor concerns. Q3 2025 deliveries reached 13,201 vehicles, slightly above expectations. 2025 full-year delivery guidance narrowed to ...
The initiative, unveiled Wednesday morning, positions VisionSys to acquire and stake up to $500 million in Solana (CRYPTO: SOL) within six months, with a long-term target of $2 billion. Marinade ...
Super Micro Computer Inc. saw its stock tumble 15% in after-hours trading Tuesday, after pre-announcing a big March-quarter shortfall — and the transition to new Nvidia Corp. chips could be the reason ...
AST SpaceMobile fell about 14% pre-market, swinging between $37.51 and $42.98. Weak quarterly results: $0.41 per share loss and $1.16M revenue missed expectations. Analysts split: potential for ...
Artificial intelligence chipmaker Ambiq Micro Inc. today delivered its first quarterly earnings report since going public in July, but investors were unimpressed with its results and voted with their ...
World of Tanks Modern Armor third annual Metal Fest is now live, running until September 15. The collaboration for the free-to-play shooter this year is the legendary rock band KISS. A rock ‘n’ roll ...
The stock of Cracker Barrel Old Country Store, Inc., tanked in the wake of its new logo redesign, which has prompted accusations that the iconic Southern restaurant franchise has been overtaken by ...
Cracker Barrel’s modern makeover doesn’t stop with redoing its restaurants. It’s dropping the barrel and the man from its logo, too. On Tuesday, the Southern-inspired casual dining chain unveiled a ...
New York (CNN) — Cracker Barrel’s modern makeover doesn’t stop with redoing its restaurants. It’s dropping the barrel and the man from its logo, too. On Tuesday, the Southern-inspired casual dining ...
New York (CNN) — Cracker Barrel’s modern makeover doesn’t stop with redoing its restaurants. It’s dropping the barrel and the man from its logo, too. On Tuesday, the Southern-inspired casual dining ...
Shares of Viking Therapeutics VKTX plunged 42% yesterday after it reported top-line data from the phase II VENTURE-Oral Dosing study, which evaluated the safety and efficacy of the oral formulation of ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈